If you're worried about not having a clean bowel movement, try chia seeds. A dietitian shares 6 ways they can relieve ...

Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

Lexeo Therapeutics received a breakthrough therapy designation from the Food and Drug Administration for its treatment for Friedreich's ataxia. Ataxia is a rare, inherited disease that damages the ...

Costco has issued recalls on several products in 2025 due to safety concerns. Shoppers should check their purchases for ...

Breakthrough Therapy designation based on interim clinical data from Phase I/II trials showing clinically meaningful ...

KalVista Pharmaceuticals shares jumped in premarket trading Monday after the company said it has received regulatory approval for its treatment of hereditary angioedema. Shares traded 20% higher ahead ...

Creatine and pre-workout supplements may boost energy and performance during physical activities. Depending on your goals, ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary ...

Seafood is the most common way people are exposed to mercury, according to the U.S. Food and Drug Administration.

KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for ...